Haleon plc (LON:HLN) Insider Buys £86,265 in Stock

Haleon plc (LON:HLNGet Free Report) insider Marie-Anne Aymerich purchased 21,300 shares of the stock in a transaction that occurred on Friday, May 9th. The shares were purchased at an average cost of GBX 405 ($5.39) per share, with a total value of £86,265 ($114,805.70).

Haleon Trading Down 1.8%

Haleon stock opened at GBX 396.89 ($5.28) on Wednesday. The company has a market cap of £35.82 billion, a P/E ratio of 33.38, a PEG ratio of 1.49 and a beta of 0.19. The firm’s 50-day moving average is GBX 385.75 and its 200-day moving average is GBX 380.79. Haleon plc has a 1 year low of GBX 319.84 ($4.26) and a 1 year high of GBX 417.70 ($5.56). The company has a debt-to-equity ratio of 53.36, a quick ratio of 0.93 and a current ratio of 0.84.

Haleon (LON:HLNGet Free Report) last issued its quarterly earnings results on Friday, February 28th. The company reported GBX 15.80 ($0.21) earnings per share for the quarter. Haleon had a net margin of 9.66% and a return on equity of 6.54%. On average, equities analysts expect that Haleon plc will post 19.5033282 earnings per share for the current year.

Haleon Increases Dividend

The company also recently declared a dividend, which will be paid on Thursday, June 5th. Stockholders of record on Thursday, April 24th will be issued a dividend of GBX 4.60 ($0.06) per share. The ex-dividend date is Thursday, April 24th. This represents a dividend yield of 1.18%. This is a positive change from Haleon’s previous dividend of $2.00. Haleon’s payout ratio is currently 50.46%.

Wall Street Analyst Weigh In

Separately, Berenberg Bank raised their price target on shares of Haleon from GBX 456 ($6.07) to GBX 457 ($6.08) and gave the company a “buy” rating in a report on Friday, February 28th.

Get Our Latest Analysis on HLN

About Haleon

(Get Free Report)

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.

Further Reading

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.